查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1754279

2025 年至 2033 年糖尿病护理设备市场规模、份额、趋势及预测（按类型、配销通路、最终用户和地区）

Diabetes Care Devices Market Size, Share, Trends and Forecast by Type, Distribution Channel, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球糖尿病护理设备市场规模达341.9亿美元。展望未来， IMARC Group预测，到2033年，该市场规模将达到626.5亿美元，2025年至2033年的复合年增长率为6.61%。北美目前占据市场主导地位，2024年的市占率将超过38.6%。糖尿病发病率的上升、技术的快速进步、政府优惠政策的实施、可支配收入的增加、巨量资料与分析技术的融合以及老年人口的不断增长，是推动市场发展的主要因素。

全球糖尿病照护设备市场的成长是由人口老化、久坐不动的生活方式以及不良饮食习惯导致的糖尿病发病率上升所引发的。都市化进程的加速伴随着肥胖率的上升。持续血糖监测 (CGM) 系统、智慧胰岛素笔和闭环胰岛素输送等先进技术有助于提高患者的依从性和疗效。政府在提高糖尿病认知度和早期诊断方面的努力也刺激了市场的发展，尤其是在医疗基础设施不断完善的新兴经济体。例如，美敦力于2024年8月获得美国食品药物管理局 (FDA) 批准其 Simplera™ CGM（一款一次性一体化设备），并宣布与雅培建立全球合作伙伴关係，以扩展持续血糖监测 (CGM) 解决方案。此外，人工智慧 (AI) 和基于云端的资料分析技术推动了糖尿病管理解决方案的发展，从而提高了远端监控能力。发展中经济体不断增长的可支配收入和医疗保健支出促进了先进糖尿病护理设备的普及。报销政策和监管审批也加速了创新和商业化。远距医疗和数位糖尿病管理平台的进步带来了新的成长机会，尤其是远距患者监控在慢性病管理中变得越来越重要。

美国糖尿病护理设备市占率达89.5%，这得益于患者对居家糖尿病管理解决方案的需求不断增长，这些解决方案可减少患者就诊次数。例如，Dexcom于2024年8月推出了Stelo，这是美国首款非处方血糖生物感测器，可为第二型糖尿病患者和糖尿病前期患者提供全天候血糖监测，无需处方或指尖采血。此外，完善的医疗基础设施、研究设施和完善的报销政策也为新型糖尿病管理设备和解决方案的使用提供了支援。美国对连续血糖监测（CGM）设备的需求很高，尤其是胰岛素依赖型患者，因为医疗保险和私人保险都涵盖此类设备。关键产业参与者的存在，加上美国食品药物管理局（FDA）的定期产品审批，促进了技术的快速发展。消费者对微创、用户友好且具有治疗益处的设备日益增长的认知和偏好，推动了市场成长。行动应用程式和基于人工智慧的糖尿病管理工具等数位健康解决方案的广泛应用，提升了患者的参与度。妊娠糖尿病和糖尿病前期盛行率的上升进一步扩大了需求量。公私合作和研究资助推动了持续创新，增强了市场竞争格局。

糖尿病护理设备市场趋势：

糖尿病发生率上升

糖尿病盛行率的上升是推动糖尿病护理设备市场成长的主要因素。这种成长主要源自于各种生活方式的改变，包括久坐不动的习惯以及高糖高脂饮食的增加。此外，随着糖尿病病例数量的增加，对高效管理和监测工具的需求变得比以往任何时候都更加迫切。 2021年，全球约有5.37亿成年人患有糖尿病，国际糖尿病联盟估计，这一数字将持续上升，到2045年将达到7.83亿。因此，糖尿病照护设备被广泛用于改善血糖管理、最大限度地降低併发症风险、减少急诊就诊次数、改善患者预后，并提供即时资料以便快速决策。此外，高发病率也提高了人们对糖尿病的认识和紧迫感，从而鼓励人们加强对研发和创新的投入，以加快技术进步的步伐，使市场对潜在买家更具吸引力。

快速的技术进步

糖尿病护理设备市场正受到快速技术进步的影响，这些技术提高了精准度、易用性和便利性。连续血糖监测系统引入了 CGM，它可以观察患者的连续血糖曲线并提供即时血糖监测，从而增强治疗客製化和生活方式调整，从而对该市场的成长产生了积极影响。根据一份产业报告，预计到 2028 年，CGM 市场销售额将达到 200 亿美元。此外，智慧胰岛素笔配备剂量计算器，透过消除实际胰岛素剂量中的所有猜测，将高度复杂化，也促进了该市场的成长。此外，配备连接功能的创新设备的开发，使医护人员和患者之间能够无缝共享资料，也有利于市场成长。

实施优惠的政府倡议

公共卫生政策和政府措施在糖尿病护理设备市场的成长中发挥重要作用。一些政府已经意识到糖尿病对医疗保健系统的负担，并采取积极措施加以应对。据世界卫生组织称，2021年，「全球有超过4.22亿人患有糖尿病，估计其在全球范围内造成的经济负担约为1.3万亿美元。」 市场增长得益于一些组织开展宣传活动的机构，这些机构旨在向公众提供有关糖尿病风险和各种疾病管理方法的建议。此外，一些政府加大了对糖尿病护理设备成本的补贴力度，使更多民众能够负担得起这些设备，这也促进了市场的成长。此外，各种报销计画的推出，涵盖了持续血糖监测仪（CGM）等先进设备的成本，也促进了市场的成长。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球糖尿病护理设备市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 血糖监测（BGM）设备
    • 关键部分
      • 自我监测设备
      • 连续血糖监测设备
  • 胰岛素输送装置
    • 关键部分
      • 泵浦
      • 钢笔
      • 注射器
      • 喷射器

第七章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 糖尿病诊所/中心
  • 网路药局
  • 其他的

第八章：市场区隔：按最终用户

  • 医院
  • 居家护理
  • 诊断中心
  • 门诊手术中心

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • ACON Laboratories Inc.
    • Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
    • Becton Dickinson and Company
    • Bionime Corporation
    • Dexcom Inc.
    • F. Hoffmann-La Roche AG
    • Johnson & Johnson
    • Medtronic plc
    • Novo Nordisk A/S
    • Sinocare Inc.
    • Terumo Corporation
Product Code: SR112025A5746

The global diabetes care devices market size was valued at USD 34.19 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 62.65 Billion by 2033, exhibiting a CAGR of 6.61% from 2025-2033. North America currently dominates the market, holding a market share of over 38.6% in 2024. The rising incidences of diabetes, rapid technological advancements, imposition of favorable government initiatives, increasing disposable incomes, integration of big data and analytics, and escalating geriatric population are some of the major factors propelling the market.

The growing global market for diabetes care devices is triggered by a geriatric population, increasingly sedentary lifestyle, and poor diets leading to higher levels of diabetes cases. The urbanization pace continues to rise in conjunction with higher rates of obesity. Advanced technology in continuous glucose monitoring (CGM) systems, smart insulin pens, and closed-loop insulin delivery contributes to greater compliance and outcomes from the patients' end. Government efforts toward escalating diabetes awareness and early diagnosis also spur the market, especially in emerging economies with an improving healthcare infrastructure. For instance, in August 2024, Medtronic received FDA approval for its Simplera(TM) CGM, a disposable, all-in-one device, and announced a global partnership with Abbott to expand continuous glucose monitoring (CGM) solutions. Moreover, diabetes management solutions are surged by artificial intelligence (AI) and cloud-based data analytics for better remote monitoring capabilities. Rising disposable income and health care spending in developing economies enhance the adoption of advanced diabetes care devices. Reimbursement policies and regulatory approvals also speed up innovation and commercialization. The advancements in telehealth and in digital diabetes management platforms hold new growth opportunities, especially with remote patient monitoring becoming more critical in the management of chronic diseases.

The U.S. diabetes care devices market share is 89.5% owing to the accelerating demand from patients preferring home-based diabetes management solutions which will reduce their hospital visits. For example, in August 2024, Dexcom launched Stelo, the first over-the-counter glucose biosensor in the U.S., providing 24/7 glucose insights without prescriptions or fingersticks for individuals with Type 2 diabetes and prediabetes. Furthermore, well-developed healthcare infrastructure, research facilities, and established reimbursement policies support the use of novel diabetes management devices and solutions. The demand for CGM devices is high in the country, especially in the case of insulin-dependent patients, since Medicare as well as private insurances cover such devices. The presence of key industry players, combined with regular product approvals by the U.S. FDA, favors fast-paced technological development. Heightened consumer awareness and preference for devices that are minimally invasive, user-friendly, and support therapeutic benefits drive market growth. Greater adoption of digital health solution-based solutions, such as mobile apps and AI-based diabetes management tools, enhance patient engagement. The rising prevalence of gestational diabetes and prediabetes further amplifies the volume of demand. Public-private partnerships and research grants fuel continuous innovation, strengthening the market's competitive landscape.

Diabetes Care Devices Market Trends:

The Rising Incidence of Diabetes

The increasing prevalence of diabetes is a dominant factor fueling the diabetes care devices market growth. This escalation is primarily caused by various lifestyle changes, including sedentary habits and increasing consumption of high-sugar and high-fat diets. Furthermore, as the number of diabetes cases multiplies, the need for efficient management and monitoring tools becomes more critical than ever. In 2021, around 537 million adults worldwide have diabetes, a number that the International Diabetes Federation estimates will continue to rise and reach 783 million by 2045. In line with this, diabetes care devices are widely used to improve glucose management, minimize the risks of complications, reduce emergency healthcare visits, increase patient outcomes, and provide real-time data for quick decision-making. Moreover, the high incidence rates lead to greater awareness and urgency, thereby encouraging more investments in research and innovation efforts to accelerate the pace of technological advancements, making the market even more attractive to potential buyers.

The Rapid Technological Advancements

The diabetes care devices market is being shaped by rapid technological advancements that offer improved precision, ease of use, and convenience. Continuous glucose monitoring systems are introducing CGMs, which observe the continuous glucose profile of a patient and provide real-time glucose monitoring, enhancing treatment customization and lifestyle adjustments that are positively influencing the growth in this market. According to an industry report, the CGM market is expected to capture sales of USD 20 Billion by 2028. Additionally, in smart insulin pens having dose calculators, which are nothing but the incorporation of high sophistication by eliminating all the guesswork in the actual dosing of insulin, is contributing toward this market growth as well. Additionally, the development of innovative devices that are equipped with connectivity features, enabling seamless data sharing between healthcare professionals and patients, is favoring the market growth.

The Imposition of Favorable Government Initiatives

Public health policies and government initiatives play a significant role in the growth of the diabetes care devices market. Several governments are recognizing the burden that diabetes imposes on healthcare systems and are taking proactive measures to address it. According to WHO, in 2021, "over 422 million people across the world were suffering from this disease, which is estimated at around USD 1.3 trillion in its economic burden throughout the world globally." In continuation of this point, the marketing growth is contributed by organizations that organize information campaigns to advise the public in relation to a risk of encountering diabetes and various ways of disease management. Moreover, the increasing allocation of funds by several governments to subsidize the cost of diabetes care devices, making them more accessible to a broader population, is contributing to the market growth. Besides this, the introduction of various reimbursement schemes to cover the cost of advanced devices, such as continuous glucose monitoring (CGMs) is contributing to the market growth.

Diabetes Care Devices Industry Segmentation:

Analysis by Type:

  • Blood Glucose Monitoring (BGM) Devices
    • Self-Monitoring Devices
    • Continuous Glucose Monitoring Devices
  • Insulin Delivery Devices
    • Pumps
    • Pens
    • Syringes
    • Jet Injectors

Blood Glucose Monitoring (BGM) leads the market with around 65.8% of market share in 2024. These devices are dominating the market as they are highly affordable, making them accessible to a broader range of consumers. Furthermore, they are designed for user-friendliness, often requiring just a small drop of blood for accurate glucose readings. Additionally, BGM devices offer near-instantaneous results, enabling immediate action if needed, such as adjusting insulin dosage or food intake. Besides this, they are compact and easy to carry, making them convenient for people who are always on the go. This portability ensures that monitoring can happen anytime, anywhere. Moreover, BGM devices are being used for a longer period and enjoy broad acceptance among healthcare providers. In addition, they require minimal upkeep, usually replacement of test strips and occasional calibration, which makes them convenient for long-term use.

Analysis by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Diabetes Clinics/Centers
  • Online Pharmacies
  • Others

Hospital pharmacies lead the market with around 54.7% of market share in 2024. These are dominating the market as they are considered reliable and trustworthy sources for medical devices, including those for diabetes care. Furthermore, patients admitted for diabetes complications or those visiting for a routine check-up can quickly and conveniently purchase the required devices and supplies from the hospital pharmacy. In addition, they employ well-trained pharmacists who can provide expert advice on device usage, thereby adding an extra layer of reassurance for patients. Besides this, products sold in hospital pharmacies are generally subject to rigorous quality checks, ensuring that patients receive authentic and effective devices. Moreover, they offer a streamlined process for insurance claims and reimbursements, making it easier for patients to offset the costs of their diabetes care devices. Along with this, hospital pharmacies offer a comprehensive range of diabetes care devices, giving patients various options to choose from.

Analysis by End User:

  • Hospitals
  • Homecare
  • Diagnostic Centers
  • Ambulatory Surgery Centers

Hospitals leads the market with around 40.5% of market share in 2024, as they offer a one-stop solution for all medical needs, making it easier for patients to get all their diabetes-related services, including consultations, treatments, and devices. Furthermore, they employ specialists in endocrinology and diabetes care, ensuring that patients receive expert advice and treatment. In addition, hospitals have the resources to handle diabetes-related emergencies, such as diabetic ketoacidosis, which standalone clinics may not be equipped for. Apart from this, hospital-based care is often covered by insurance plans, making it a more accessible option for many patients. Moreover, the sheer number of patients that hospitals serve ensures that they purchase diabetes care devices in bulk, thus contributing to their large share of the market. Along with this, they are subjected to strict quality control standards, which provide assurance of the efficacy and safety of the diabetes care devices used.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of over 38.6%. The region has one of the highest rates of diabetes in the world, which leads to increased demand for diabetes care devices. Furthermore, the region boasts a well-developed healthcare system with widespread availability of advanced medical technologies, including diabetes care devices. Additionally, the presence of comprehensive insurance plans, which cover diabetes treatment and devices, making it convenient for patients to access the care they need, is positively influencing the market growth. Besides this, North America hosts some of the leading companies in medical device manufacturing that are continuously updating and advancing diabetes care technology. In addition, the escalating awareness about diabetes and its management among regional consumers is acting as another growth-inducing factor. Moreover, the imposition of supportive policies and initiatives by regional governments to combat diabetes and provide access to high-quality treatment is favoring the market growth.

Key Regional Takeaways:

United States Diabetes Care Devices Market Analysis

The U.S. diabetes care devices market is increasing steadily due to the prevalence of diabetes and high healthcare expenditures. According to the CDC, around 37.3 million people in America suffer from diabetes, and this makes 11.3% of the total population in the United States. This raised number is raising the demand for diabetes management products. In 2023, an estimated amount of USD 327 billion were spent on U.S. healthcare on diabetes care, most of which goes into medical devices, including CGMs and insulin pumps. Leading players in this market are Medtronic, Abbott, and Dexcom, which are moving the technologies along to include the integrated insulin delivery systems. The continued efforts towards accessibility and affordability of diabetes devices will further drive the market growth. As the country continues to push for integration of digital health, telemedicine for diabetes care is expected to augment device adoption, ensuring continued momentum in the market.

Europe Diabetes Care Devices Market Analysis

The market for diabetes care devices is increasing in Europe with increasing prevalence of diabetes and increased investment in health. IDF states that 2023 was the year when more than 60 million people were living with diabetes in Europe. Germany and UK are well ahead in using advanced diabetes care devices. These include insulin pens, CGMs, and insulin pumps. Further, cost-effective health care seems to be creating growth opportunities for the European as well as EU-wide markets. There is a wide effort to curb chronic diseases that is also working for the industry's growth. Smart insulin pens, wireless glucose monitoring systems are other innovative products coming from leaders such as Roche and Bayer. The regulation framework in Europe about diabetes care products, safety and effectiveness in treatment, facilitates the innovation in market growth.

Asia Pacific Diabetes Care Devices Market Analysis

Asia Pacific diabetes care devices market is highly growing due to the increasing diabetes rates and geriatric population. IDF reports that more than 170 million people are suffering from diabetes, and the population of China and India is leading in this segment. An industrial report suggests that China's diabetes care market was at USD 4.7 billion in 2023, and considerable investments have been made into the advanced medical devices, which include CGMs and insulin delivery systems. In India, the diabetes care device markets also grow as more emphasis is being put upon cost-effective and affordable solutions. Healthcare infrastructure growth and adoption of digital health solutions have spurred the demand for diabetes devices in this region. Innovation and access to products is also driven through partnerships between international and local players, such as Abbott and Medtronic collaborating in India. Government-backed programs for increasing the accessibility of better diabetes care in the region continue to fuel the growth of this market.

Latin America Diabetes Care Devices Market Analysis

In terms of the high prevalence of diabetes in Latin America, Brazil accounts for over 15.7 million adults who are already affected, a figure provided by the International Diabetes Federation (IDF) of 2021. This explains why the high prevalence of the disease has driven up healthcare costs in the country. As per industrial reports, in 2021, a total of 42.93 billion USD had been allocated toward diabetes care within Brazil. Given the trend this amount is believed to increase profoundly in the forthcoming years, surging to a total of about 48.31 billion in 2030 and 51.44 billion in 2045. In other words, it is directly proportional to increasing disease burden. Moreover, the Brazilian government tries to expand the use of advanced technologies in the treatment of very high medical specialties like insulin pumps, continuous glucose monitors (CGMs), and insulin pens, along with expanding the public knowledge and patient's perception. The overall approach to that is driven by Novo Nordisk, Sanofi, and other key market players with very critical treatment options and increasingly adequate technologies for satisfying the present demand.

Middle East and Africa Diabetes Care Devices Market Analysis

The International Diabetes Federation (IDF) estimates around 73 million adults in the Middle East and North Africa, also known as the MENA region. The statistics show that the prevalence among adults in Saudi Arabia is nearly 17.7%, and about 4.27 million people are diagnosed with diabetes in the country, while South Africa is also the region's 'hot spot'. This boosting trend is due to the growing diabetes care market in the country. Current government action, such as healthcare initiatives that offer cheap access to diabetes care equipment, has been proved to impact the aspect comprehensively. Saudi Arabia has also accentuated the healthcare infrastructure, and campaigns to educate the people about diabetes management. Therefore, the diabetes care market in Saudi Arabia is growing, as demand for insulin pumps and continuous glucose monitoring (CGM) devices is increasing along with other advanced solutions for efficient management of the disease.

Competitive Landscape:

Leadership companies are moving towards bringing next-generation products in the pipeline to market, such as smart insulin pens, CGM integrated devices and much accurate meters for checking the blood sugar. Additionally, major companies are developing partnership arrangements with health-care organisations, IT organizations and sometimes, competitors for designing new devices jointly. Moreover, key companies have developed differentiated product lines which suit emerging geographies where the risk of developing the disease is escalating. They are also integrating digital technologies, such as data analytics and telehealth, into their devices to allow real-time monitoring and data collection, which can be crucial for effective diabetes management. Several companies are investing in education programs and materials to help users understand how to manage diabetes effectively. Along with this, they are leveraging online platforms for direct sales and customer engagement.

The report provides a comprehensive analysis of the competitive landscape in the diabetes care devices market with detailed profiles of all major companies, including:

  • Abbott Laboratories
  • ACON Laboratories Inc.
  • Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
  • Becton Dickinson and Company
  • Bionime Corporation
  • Dexcom Inc.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Medtronic plc
  • Novo Nordisk A/S
  • Sinocare Inc.
  • Terumo Corporation

Key Questions Answered in This Report

  • 1.How big is the diabetes care devices market?
  • 2.What is the future outlook of diabetes care devices market?
  • 3.What are the key factors driving the diabetes care devices market?
  • 4.Which region accounts for the largest diabetes care devices market share?
  • 5.Which are the leading companies in the global diabetes care devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Diabetes Care Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Blood Glucose Monitoring (BGM) Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Self-Monitoring Devices
      • 6.1.2.2 Continuous Glucose Monitoring Devices
    • 6.1.3 Market Forecast
  • 6.2 Insulin Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Pumps
      • 6.2.2.2 Pens
      • 6.2.2.3 Syringes
      • 6.2.2.4 Jet Injectors
    • 6.2.3 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacies
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diabetes Clinics/Centers
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Online Pharmacies
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Diagnostic Centers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Ambulatory Surgery Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 ACON Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Ascensia Diabetes Care Holdings AG (PHC Holdings Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bionime Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Dexcom Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Johnson & Johnson
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Medtronic plc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Novo Nordisk A/S
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sinocare Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Terumo Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Diabetes Care Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Diabetes Care Devices Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Diabetes Care Devices Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Diabetes Care Devices Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Diabetes Care Devices Market: Breakup by Distribution Channel (in %), 2024
  • Figure 6: Global: Diabetes Care Devices Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Diabetes Care Devices Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Diabetes Care Devices (Blood Glucose Monitoring (BGM) Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Diabetes Care Devices (Blood Glucose Monitoring (BGM) Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Diabetes Care Devices (Insulin Delivery Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Diabetes Care Devices (Insulin Delivery Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Diabetes Care Devices (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Diabetes Care Devices (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Diabetes Care Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Diabetes Care Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Diabetes Care Devices (Diabetes Clinics/Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Diabetes Care Devices (Diabetes Clinics/Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Diabetes Care Devices (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Diabetes Care Devices (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Diabetes Care Devices (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Diabetes Care Devices (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Diabetes Care Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Diabetes Care Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Diabetes Care Devices (Homecare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Diabetes Care Devices (Homecare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Diabetes Care Devices (Diagnostic Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Diabetes Care Devices (Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Diabetes Care Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Diabetes Care Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Diabetes Care Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Diabetes Care Devices Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Diabetes Care Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Diabetes Care Devices Industry: SWOT Analysis
  • Figure 80: Global: Diabetes Care Devices Industry: Value Chain Analysis
  • Figure 81: Global: Diabetes Care Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Diabetes Care Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Diabetes Care Devices Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Diabetes Care Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 4: Global: Diabetes Care Devices Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Diabetes Care Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Diabetes Care Devices Market: Competitive Structure
  • Table 7: Global: Diabetes Care Devices Market: Key Players